Trupanion, Inc. (NASDAQ:TRUP) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have received a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $45.14.

TRUP has been the subject of several analyst reports. Piper Sandler decreased their price objective on Trupanion from $32.00 to $28.00 and set a “neutral” rating for the company in a report on Friday, November 3rd. StockNews.com raised Trupanion from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th.

Trupanion Stock Performance

Shares of TRUP stock opened at $26.57 on Tuesday. The stock has a market cap of $1.10 billion, a PE ratio of -21.09 and a beta of 1.66. The business has a 50-day simple moving average of $25.32 and a 200-day simple moving average of $25.69. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.44. Trupanion has a 52-week low of $18.45 and a 52-week high of $69.15.

Insider Buying and Selling

In other Trupanion news, Director Michael Doak sold 8,688 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $29.99, for a total transaction of $260,553.12. Following the completion of the sale, the director now directly owns 5,866 shares in the company, valued at approximately $175,921.34. The transaction was disclosed in a document filed with the SEC, which is available through this link. 5.81% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Trupanion

Large investors have recently bought and sold shares of the company. Cerity Partners LLC purchased a new stake in Trupanion during the 1st quarter worth approximately $970,000. Belpointe Asset Management LLC grew its position in shares of Trupanion by 2,500.0% in the first quarter. Belpointe Asset Management LLC now owns 832 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 800 shares in the last quarter. Captrust Financial Advisors grew its position in shares of Trupanion by 162.6% in the first quarter. Captrust Financial Advisors now owns 893 shares of the financial services provider’s stock valued at $80,000 after purchasing an additional 553 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of Trupanion by 128.4% in the first quarter. Tower Research Capital LLC TRC now owns 1,039 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 584 shares in the last quarter. Finally, BluePath Capital Management LLC purchased a new stake in shares of Trupanion in the third quarter valued at approximately $31,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.